Novo Nordisk
NVO
NVO
516 hedge funds and large institutions have $11.2B invested in Novo Nordisk in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 178 increasing their positions, 204 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.97% more ownership
Funds ownership: 18.96% → 19.92% (+0.97%)
3% less funds holding in top 10
Funds holding in top 10: 32 → 31 (-1)
13% less repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 204
Holders
516
Holding in Top 10
31
Calls
$14.6M
Puts
$9.12M
Top Buyers
| 1 | +$175M | |
| 2 | +$124M | |
| 3 | +$111M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$77.4M |
| 5 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$49.3M |
Top Sellers
| 1 | -$197M | |
| 2 | -$60.5M | |
| 3 | -$23.4M | |
| 4 |
Bank of New York Mellon
New York
|
-$21.9M |
| 5 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
-$20.9M |